Indeed, treatments with IL-6 and EGF activated Pyk2 and FAK phosphorylation in all evaluated glioma cell lines (Figure 2), while the effect of PDGFβ, SDF-1α, and IL-8 was patient dependent. The gene discussed is CXCL12; the disease is central nervous system cancer.